CAPR · Capricor Therapeutics, Inc. · Investor Relations
$6.61
-0.04 (-0.60%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$384.30M
Shares
58.14M
Volume · Oct 20
2.05M
Avg daily vol (3M)
7M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-10-07 | PPMD webinar (HOPE-3 OLE data) | Event |
| 2026-10-03 | 31st Annual Congress of the World Muscle Society (WMS 2026) | Event |
| 2026-08-13 | Capricor Therapeutics Second Quarter 2026 Financial Results and Corporate Update Conference Call | Earnings call |
| 2026-06-27 | PPMD's 2026 Annual Conference | Conference |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-24 | CureDuchenne 2026 FUTURES National Conference | Conference |
| 2026-05-15 | American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting | Shareholder meeting |
| 2026-05-12 | Capricor Therapeutics First Quarter 2026 Financial Results and Corporate Update Conference Call | Earnings call |
| 2026-03-12 | Capricor Therapeutics Fourth Quarter 2025 Financial Results and Corporate Update Conference Call | Earnings call |
| 2026-03-11 | 2026 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference | Conference |
Key facts
CIK
1133869
CUSIP
14070B309
13F (30d)
10 filings
10 filers
Visit website
Investor relations